https://acadia.com/media/news-releases/acadia-pharmaceuticals-and-neuren-pharmaceuticals-announce-exclusive-license-agreement-for-the-north-american-development-and-commercialization-of-trofinetide-in-rett-syndrome/
p2 trials had been released. They stepped in to fund p3 and get exclusive licensing deal.
p2 has get dropped first and has to be good, before any deal. Wouldn't make any sense otherwise.
- Forums
- ASX - By Stock
- Results to Seal a Deal
https://acadia.com/media/news-releases/acadia-pharmaceuticals-and...
-
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.2¢ |
Change
-0.001(4.35%) |
Mkt cap ! $19.85M |
Open | High | Low | Value | Volume |
2.2¢ | 2.3¢ | 2.1¢ | $5.848K | 265.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1098181 | 2.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.2¢ | 97130 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1098181 | 0.021 |
2 | 1031363 | 0.020 |
1 | 225000 | 0.019 |
6 | 491000 | 0.018 |
6 | 725352 | 0.017 |
Price($) | Vol. | No. |
---|---|---|
0.022 | 97130 | 1 |
0.023 | 1449422 | 4 |
0.024 | 500000 | 1 |
0.025 | 223000 | 3 |
0.028 | 95406 | 3 |
Last trade - 15.32pm 17/09/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |